scholarly article | Q13442814 |
P356 | DOI | 10.1095/BIOLREPROD.106.059642 |
P698 | PubMed publication ID | 17287493 |
P50 | author | István Kovanecz | Q71914030 |
P2093 | author name string | Rajfer J | |
Gonzalez-Cadavid NF | |||
Vernet D | |||
Sanchez S | |||
Davila HH | |||
Ferrini MG | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | erectile dysfunction | Q184674 |
P304 | page(s) | 915-923 | |
P577 | publication date | 2007-02-07 | |
P1433 | published in | Biology of Reproduction | Q4915061 |
P1476 | title | Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat | |
P478 | volume | 76 |
Q38257165 | 2013-2014 updates in Peyronie's disease management |
Q38406941 | Administration of Goji (Lycium chinense Mill.) Extracts Improves Erectile Function in Old Aged Rat Model |
Q38738470 | Aging and sexual health: getting to the problem |
Q37647240 | Aging related erectile dysfunction-potential mechanism to halt or delay its onset |
Q35570950 | Amelioration of diabetes-induced cavernosal fibrosis by antioxidant and anti-transforming growth factor-β1 therapies in inducible nitric oxide synthase-deficient mice |
Q46987652 | Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection |
Q51548207 | Chronic prostatitis/chronic pelvic pain syndrome impairs erectile function through increased endothelial dysfunction, oxidative stress, apoptosis, and corporal fibrosis in a rat model. |
Q26775925 | Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update |
Q37030511 | Daily use of phosphodiesterase 5 inhibitors for erectile dysfunction and lower urinary tract symptoms |
Q37630425 | Diabetes and sexual dysfunction: current perspectives. |
Q91297820 | Early improvement in SHIM scores with Revactin® |
Q46738229 | Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. |
Q48459547 | Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. |
Q30462352 | Effects of sildenafil and/or muscle derived stem cells on myocardial infarction |
Q87946329 | Effects of the recreational use of PDE5 inhibitors on the corpus cavernosum of young, healthy rats |
Q37594796 | Efficacy of Cinnamomum cassia Blume. in age induced sexual dysfunction of rats |
Q62029106 | Erectile dysfunction |
Q34403822 | Erectile hydraulics: maximizing inflow while minimizing outflow |
Q42781883 | Erectile tissue molecular alterations with aging: differential activation of the p42/44 MAP Kinase pathway |
Q37171963 | Erectogenic and Aphrodisiac Effects of Butea frondosa Koenig ex Roxb. in Rats: Involvement of Enzyme Inhibition |
Q42696988 | Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue. |
Q37373199 | Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. |
Q37085433 | Improvement of erectile function by Korean red ginseng (Panax ginseng) in a male rat model of metabolic syndrome |
Q46991340 | Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. |
Q38568077 | PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT. |
Q51134530 | Penile rehabilitation after pelvic cancer surgery. |
Q26773762 | Penile rehabilitation after radical prostatectomy: does it work? |
Q21328700 | Penile rehabilitation therapy with PDE-V inhibitors following radical prostatectomy: proceed with caution |
Q26768640 | Peyronie's disease: What's around the bend? |
Q37865017 | Peyronie's disease: perspectives on therapeutic targets |
Q86490946 | Pharmacokinetic interaction between Kaempferia parviflora extract and sildenafil in rats |
Q37526780 | Prediction of sexual function after radical prostatectomy. |
Q89475315 | Reduction of oxidative stress markers in the corpora cavernosa and media of penile dorsal artery in middle-aged rats treated with COMP-4 |
Q55078470 | Safety and efficacy of daily Revactin® in men with erectile dysfunction: a 3-month pilot study. |
Q35610039 | Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice |
Q41600750 | Separate or combined treatments with daily sildenafil, molsidomine, or muscle-derived stem cells prevent erectile dysfunction in a rat model of cavernosal nerve damage. |
Q34486470 | Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damage |
Q43485171 | Sildenafil citrate improves erectile function after castration in a rat model |
Q34788065 | Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat |
Q43007162 | Testosterone and chronic sildenafil/tadalafil anti-apoptotic role in aged diabetic rats |
Q90054817 | The Effects of Calorie Restriction and Exercise on Age-Related Alterations in Corpus Cavernosum |
Q36463526 | The aging penis: what is it trying to tell us? |
Q91785916 | The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective |
Q38902584 | Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction |
Q37704966 | Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy |
Q36082711 | Treatment with a combination of ginger, L-citrulline, muira puama and Paullinia cupana can reverse the progression of corporal smooth muscle loss, fibrosis and veno-occlusive dysfunction in the aging rat. |
Q38630432 | Treatments for fibrosis of the corpora cavernosa |
Q45938670 | [Cavernous tissue rehabilitation whit sildenafil 100 mg in patients after radical prostatectomy]. |
Search more.